prof. MUDr. Miroslav Penka, CSc.

2020

• Pharmacokinetic Comparison of Subcutaneous and Intravenous Nadroparin Administration for Thromboprophylaxis in Critically Ill Patients on Vasopressors

  CIHLÁŘ Radek ŠRÁMEK Vladimír PAPIEŽ Adriána PENKA Miroslav SUK Pavel

  Article in Periodical

  PHARMACOLOGY, year: 2020, volume: 105, edition: 1-2, DOI

• Provoz na velkokapacitním hematologickém analyzátoru Abbott Alinity hq

  KLINEROVÁ Jana BOURKOVÁ Ludmila HOBLOVÁ Jaroslava PENKA Miroslav

  Conference abstract

  Year: 2020, type: Conference abstract

• Transplantace jater jako potenciální kurativní metoda těžké hemofilie A: popis případu a literární přehled

  POLÁK Pavel SMEJKAL Petr ROMANOVÁ Gabriela ZAVŘELOVÁ Jiřina HRDLIČKOVÁ Radomíra BLAHUTOVÁ Šárka HUSOVÁ Libuše ZVAROVÁ Marta PENKA Miroslav

  Article in Periodical

  Vnitřní lékařství, year: 2020, volume: 66, edition: 5

• Von Willebrand Disease (VWD): Diagnostic Differentiation of Pseudo, Mild, Moderate to Severe VWD Type 1 and 2 by a DDAVP Challenge Test on Top of the ISTH Classification

  MICHIELS J. J. HERMANS C. SMEJKAL Petr PENKA Miroslav BATOROVA A. PRICANGOVA T. BUDDE U. GADISSEUR A. VAN VLIET H.

  Article in Periodical

  Thrombosis & haemostasis: research, year: 2020, volume: 4, edition: 1

2019

• Analysis of carriers of type 3 von Willebrand disease caused by heterozygous deletion c.2435delC in South Moravian region

  SMEJKAL Petr ZAVŘELOVÁ Jiřina ZAPLETAL Ondřej VANGENECHTEN I. GADISSEUR A. ROMANOVÁ Gabriela POLAK P. BLATNÝ Jan MICHIELS J. J. PENKA Miroslav

  Conference abstract

  Year: 2019, type: Conference abstract

• Analysis of von Willebrand Disease in the South Moravian Population (Czech Republic): Results from the BRNO-VWD Study

  VANGENECHTEN Inge SMEJKAL Petr ZAPLETAL Ondřej MICHIELS Jan Jacques BERNEMAN Zwi ZAVŘELOVÁ Jiřina BLATNÝ Jan PENKA Miroslav GADISSEUR Alain

  Article in Periodical

  THROMBOSIS AND HAEMOSTASIS, year: 2019, volume: 119, edition: 4, DOI

• Basic Insights into the Molecular Etiology and Pathology of Von Willebrand Factor (VWF) Behind the ISTH And ECLM Classifications of Von Willebrand Disease Using a Complete Set of VWF Parameterss

  MICHIELS J. J. SMEJKAL Petr PENKA Miroslav BLATNÝ J. BUDDE U. HERMANS C. BATOROVA A. PRICANGOVA T. VANGENECHTEN I. GADISSEUR A.

  Article in Periodical

  Austin Hematology, year: 2019, volume: 4, edition: 1

• Combined Use of Rapid Von Willebrand Factor (VWF) Activity, VWF-Propetide and Classical VWF Assays for Improved Diagnosis of Von Willebrand Disease Type 1, 2N and 2E Due to Mutations in the D1, D2, D’, D3 and D4 Domains of the VWF Gene

  MICHIELS J. J. SMEJKAL Petr MOORE G. BUDDE U. BERNEMAN Z. VANGENECHTEN I. GADISSEUR A. BLATNY J. PENKA Miroslav

  Article in Periodical

  Thrombosis & Haemostasis: Research, year: 2019, volume: 3, edition: 2

• European Clinical, Laboratory and Molecular (2020 ECLM) Diagnostic Work-Up and Classification of Von Willebrand Disease from the Perspectives of Clinicians and Scientists

  SMEJKAL Petr MICHIELS J. J. ZAPLETAL Ondřej BLATNÝ Jan BATOROVA A. PRICANGOVA T. BUDDE U. HERMANS C. MAYGER K. MOORE G. VANGENEGTEN I. PENKA Miroslav

  Article in Periodical

  Thrombosis & Haemostasis: Research, year: 2019, volume: 3, edition: 3

• High level of circulat ing microparticles in patients with BCR/ ABL negative myeloproliferative neoplasm - A pilot study

  ASWAD Mohamed Hussam KISSOVÁ Jarmila ŘÍHOVÁ Lucie ZAVŘELOVÁ Jiřina OVESNÁ Petra PENKA Miroslav

  Article in Periodical

  Klinická onkologie, year: 2019, volume: 32, edition: 2, DOI